Skip to main content
OpenTrials

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

404 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Completed

A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

NCT06010303

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 38 locations
View Trial Details
Completed

A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma

NCT03957590

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 33 locations
View Trial Details
Completed

A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

NCT04785820

Conditions
Advanced or Metastatic Esophageal Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +13 more
Locations
  • Inst. Alexander Fleming Buenos Aires, Argentina
  • Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina
  • Hospital das Clinicas - UFRGS Porto Alegre, Rio Grande do Sul, Brazil
  • Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo, Brazil
View all 52 locations
View Trial Details
Completed

Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.

NCT05142709

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • The 2nd affiliated hospital of Bengbu medical University Bengbu, Anhui, China
  • The 2nd people's hospital of Anhui province Hefei, Anhui, China
  • Fujian Cancer Hospital & Fujian Medical University Cancer Hospital Fuzhou, Fujian, China
  • The 1st affiliated hospital of Xiamen University Xiamen, Fujian, China
View all 23 locations
View Trial Details
Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

NCT05342636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Liga Norte Riograndense Contra o Câncer ( Site 2303) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceição ( Site 2301) Porto Alegre, Rio Grande do Sul, Brazil
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300) São Paulo, Brazil
  • FALP-UIDO ( Site 2400) Santiago, Region M. de Santiago, Chile
View all 46 locations
View Trial Details

Related conditions